期刊文献+

方和谦经验方加味和肝汤治疗慢性浅表性胃炎临床研究 被引量:2

Clinical study of FANG He-qian's proved recipe Jiaweihegan decoction on chronic superficial gastritis
下载PDF
导出
摘要 目的观察以方和谦教授经验方加味和肝汤治疗慢性浅表性胃炎临床疗效。方法按照随机对照试验将130例慢性浅表性胃炎患者随机分为加味和肝汤组50例、辨证治疗组40例和常规西药组40例。分别采用口服加味和肝汤、中医药辨证汤剂及西药吉法酯治疗。3组均以30天为1个疗程,共治疗2个疗程。比较3组治疗前后症状体征以及胃镜疗效。结果加味和肝汤组症状积分下降较辨证治疗组、常规西药组均明显,差异均有统计学意义(P<0.05);3组间症状总有效率比较差异有统计学意义(χ2=13.582,P<0.01);加味和肝汤组胃镜有效率达84.0%,3组间胃镜疗效总有效率比较差异有统计学意义(χ2=6.546,P<0.05)。结论加味和肝汤可以明显改善患者临床症状及胃镜下表现。 Objective To observe the clinical efficacy of Professor FANG He-qian's proved recipe,Jiaweihegan decoction on chronic superficial gastritis.Methods According to randomized controlled trial,one hundred and thirty cases of chronic superficial gastritis were randomly divided into a Jiaweihegan decoction group(JD group,n=50) that was orally administrated Jiaweihegan decoction,a syndrome differentiation group(SD group,n=40) treated with syndrome differentiation decoctions and a conventional Western medicine group(WM group,n=40) that was orally administrated gefarnate.30 days composed one course of treatment and 2 courses were required.The symptoms,signs and efficacy observed by gastroscope before and after the treatment were compared in the three groups.Results The symptom score in the JD group was more obviously decreased than that in the SD group and the WM group(P0.05);there was significant between-group difference in total effective rate of symptom efficacy(χ2=13.582,P0.01);in the JD group,the effective rate by gastroscope reached 84%,and there was significant between-group difference in total effective rate by gastroscope(χ2=6.546,P0.05).Conclusion Jiaweihegan decoction could apparently improve the clinical symptoms and manifestations under gastroscope.
作者 权红 解晓静
出处 《北京中医药》 2013年第5期346-348,共3页 Beijing Journal of Traditional Chinese Medicine
基金 2010年度北京市中医药科技发展基金(JJ-2010-06)
关键词 方和谦 老中医经验 加味和肝汤 慢性浅表性胃炎 FANG He-qian old TCM doctors' experience Jiaweihegan decoction chronic superficial gastritis
  • 相关文献

参考文献2

二级参考文献93

  • 1韩跃华,刘文忠,朱红音,萧树东.上海地区幽门螺杆菌菌株iceA、babA2基因型与临床的关系[J].中华消化杂志,2004,24(6):322-325. 被引量:14
  • 2周丽雅,林三仁,丁士刚,黄雪彪,郭长吉,张莉,崔荣丽,金珠,孟灵梅,张静.根除幽门螺杆菌对胃癌患病率及胃黏膜组织学变化的八年随访研究[J].中华消化杂志,2005,25(6):324-327. 被引量:87
  • 3刘新光,贾博琦,林三仁,叶嗣懋,董秀云,陈寿坡,戴希真.替普瑞酮对慢性浅表性胃炎疗效的临床研究[J].中华内科杂志,1996,35(1):12-18. 被引量:43
  • 4曹勤,冉志华,萧树东.血清胃蛋白酶原、胃泌素-17和幽门螺杆菌IgG抗体筛查萎缩性胃炎和胃癌[J].胃肠病学,2006,11(7):388-394. 被引量:113
  • 5Hojo M,Miwa H,Ohkusa T,Ohkura R,Kurosawa A,Sato N.Alteration of histological gastritis after cure of Helicobacter pylori infection.Aliment Pharmacol Ther,2002,16:1923~1932.
  • 6Borch K,Jonsson KA,Petersson F,Redeen S,Mardh S,Franzen LE.Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample:relations to symptomatology and life-style.Dig Dis Sci,2000,45:1322~1329.
  • 7Redeen S,Petersson F,Jonsson KA,Borch K.Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample.Endoscopy,2003,35:946~950.
  • 8Annibale B,Negrini R,Caruana P,Lahner E,Grossi C,Bordi C,Delle Fave G.Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection.Helicobacter,2001,6:225~233.
  • 9Annibale B,Di Giulio E,Caruana P,Lahner E,Capurso G,Bordi C,Delle Fave G.The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis.Aliment Pharmacol Ther,2002,16:1723~1731.
  • 10Vaananen H,Vauhkonen M,Helske T,Kaariainen I,Rasmussen M,Tunturi-Hihnala H,Koskenpato J,Sotka M,Turunen M,Sandstrom R,Ristikankare M,Jussila A,Sipponen P.Non-endoscopic diagnosis of atrophic gastritis with a blood test.Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen Ⅰ:a multicentre study.Eur J Gastroenterol Hepatol,2003,15:885~891.

共引文献882

同被引文献48

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部